European Journal of Neurodegenerative Diseases 2019; 8(1) January-June: 5-7


EPINEPHRINE AND NOREPINEPHRINE INCREASE LYMPHOCYTE MIGRATION IN A DOSE-DEPENDENT MANNER

Letter to the Editor

I. Frydas *

Aristotelian University, Laboratory of Microbiology and Infectious Diseases, School of Veterinary Medicine, Thessaloniki, Greece.

*Correspondence to:
Ilias Frydas, MD,
Laboratory of Microbiology and Infectious Diseases,
School of Veterinary Medicine,
Aristotle University of Thessaloniki,
Thessaloniki, Greece.
e-mail: frydas@vet.auth.gr

Received: 18 January, 2019
Accepted: 02 March, 2019

adobe-pdf-download-icon

2279-5855 (2019)
Copyright © by BIOLIFE
This publication and/or article is for individual use only and may not be further reproduced without written permission from the copyright holder. Unauthorized reproduction may result in financial and other penalties. Disclosure: all authors report no conflicts of interest relevant to this article.

KEYWORDS: epinephrine, norepinephrine, lymphocyte, inflammation, immune response

 

INTRODUCTION

 

Epinephrine and norepinephrine are endogenous anti-inflammatory catecholamines, highlighted in the 1960s by Spector and Willoughby (1). They are immediately released after an inflammatory process as a protective response to try to restore the normal physiological state of the tissue. Furthermore, norepinephrine inhibits vascular permeability, an effect that characterizes the inflammatory process (2).

Catecholamines are endogenous compounds that have long been known to modulate inflammatory responses (3-6). Receptors for catecholamines have been shown on the lymphocyte cell membrane; neurotransmitter agonists and antagonists have been used to study lymphocyte proliferation and modulate antibody synthesis (7,8). Catecholamines inhibit NF-kB in various cell types via the activation of cyclic AMP/protein kinase A (cAMP/PKA), which leads to the activation of 5’ adenosine monophosphate-activated protein kinase (AMPK) (9). In addition, epinephrine and norepinephrine inhibit NF-kB, which leads to the suppression of pro-inflammatory cytokines (5).

Here, in this study, we report that epinephrine and norepinephrine increase the migration of lymphocytes in outbred young rats.

 

Chemotaxis assay:

Wistar rats were used as donors of lymphocytes from the thymus. The tissues were minced and passed through cotton wool and a nylon filter to eliminate the cell debris. After filtering the cells, they were washed in Eagle’s minimal essential medium and spun at 150 x g.

Lymphocyte locomotion assay was performed using modified Boyden chambers. A cell suspension of 0.5 ml (1×106 cells/ml) was pipetted into the upper compartment of the chamber, which was separated from the epinephrine or norepinephrine-containing compartment below by an 8 mm pores filter. After incubation (at 37°C for 5 h), the filters were fixed, and cells were counted at every 10 mm level, starting from the proximal to distal surface. The locomotion index (LI+m) was calculated as described by Moderato et al. (10).

 

RESULTS AND DISCUSSION

 

In this paper, we show that epinephrine or norepinephrine enhances the migration of lymphocytes in a dose-dependent manner. The dose-response bars are shown in Fig. 1(Fig.1). The locomotion index, LI+m of the controls, is 22.5 +/- 0.9.

 

Fig. 1. Effect of epinephrine and norepinephrine on the migration of rat thymus lymphocytes. Epinephrine treatment causes an increase in lymphocyte migration (black bars) compared to lymphocyte migration without treatment (white bars). Similar effects were obtained when the cells were treated with norepinephrine. These results show that these two catecholamines increase lymphocyte migration in a dose-dependent manner.

 

Here we show that epinephrine or norepinephrine stimulates the migration of rat thymus lymphocytes in physiological and pathophysiological concentrations, an effect that makes these two catecholamines important players in the dynamics of the inflammatory and immunological responses.

 

Conflict of interest

The author declares that they have no conflict of interest.

 

REFERENCES

 

  1. Willoughby DA, Spector WG. Adrenaline precursors in the inflammatory reaction. The Journal of Pathology and Bacteriology. 1964;88(1):159-166. doi:https://doi.org/10.1002/path.1700880121
  2. Farand P, Hamel M, Lauzier F, Plante GE, Lesur O. Review article: Organ per fusion/permeability related effects of norepinephrine and vasopressin in sepsis. Canadian Journal of Anesthesia/Journal canadien d’anesthésie. 2006;53(9):934-946. doi:https://doi.org/10.1007/bf03022837
  3. Flierl MA, Rittirsch D, Huber-Lang M, Sarma JV, Ward PA. Catecholamines—Crafty Weapons in the Inflammatory Arsenal of Immune/Inflammatory Cells or Opening Pandora’s Box? Molecular Medicine. 2008;14(3-4):195-204. doi:https://doi.org/10.2119/2007-00105.Flierl
  4. Swanson MA, Lee WT, Sanders VM. IFN-γ Production by Th1 Cells Generated from Naive CD4+ T Cells Exposed to Norepinephrine. The Journal of Immunology. 2001;166(1):232-240. doi:https://doi.org/10.4049/jimmunol.166.1.232
  5. Barnes MA, Carson MJ, Nair MG. Non-traditional cytokines: How catecholamines and adipokines influence macrophages in immunity, metabolism and the central nervous system. Cytokine. 2015;72(2):210-219. doi:https://doi.org/10.1016/j.cyto.2015.01.008
  6. Andersson U, Tracey KJ. Neural reflexes in inflammation and immunity. Journal of Experimental Medicine. 2012;209(6):1057-1068. doi:https://doi.org/10.1084/jem.20120571
  7. Sanders VM, Baker RA, Ramer-Quinn DS, Kasprowicz DJ, Fuchs BA, Street NE. Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. The Journal of Immunology. 1997;158(9):4200-4210. doi:https://doi.org/10.4049/jimmunol.158.9.4200
  8. Bergquist J, Tarkowski A, Ekman R, Ewing A. Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. Proceedings of the National Academy of Sciences. 1994;91(26):12912-12916. doi:https://doi.org/10.1073/pnas.91.26.12912
  9. Serezani CH, Ballinger MN, Aronoff DM, Peters-Golden M. Cyclic AMP. American Journal of Respiratory Cell and Molecular Biology. 2008;39(2):127-132. doi:https://doi.org/10.1165/rcmb.2008-0091tr
  10. Maderazo EG, Woronick CL. Micropore filter assay of human granulocyte locomotion: Problems and solutions. Clinical Immunology and Immunopathology. 1978;11(2):196-211. doi:https://doi.org/10.1016/0090-1229(78)90044-2

 

You may also like...